Alkermes plc Depreciation & Amortization 2011-2026 | ALKS

Annual Depreciation & Amortization Alkermes plc

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
27.2 M	28.5 M	74.9 M	77.9 M	78.7 M	81.9 M	80.4 M	104 M	98.5 M	94.3 M	85.6 M	98.1 M	73.8 M	47.9 M	8.65 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
104 M	8.65 M	70.7 M

Quarterly Depreciation & Amortization Alkermes plc

2026-Q1	2025-Q4	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
19.4 M	-	-	7.42 M	-	14 K	14 K	8.06 M	-	9 M	8.9 M	18.7 M	-	9.17 M	9.07 M	19.2 M	-	57.5 M	9.51 M	19.6 M	-	61.5 M	40.9 M	20.6 M	-	59.9 M	39.6 M	19.6 M	-	77.8 M	51.5 M	25.7 M	-	73.3 M	48.3 M	23.8 M	-	69.6 M	45.8 M	22.7 M	-	63.8 M	43.1 M	22.5 M	-	72.7 M	47.5 M	22.6 M	-	65.7 M	23.7 M	18.3 M	10.5 M	10.5 M	36.8 M	-	11.9 M	27.3 M	6.38 M	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
77.8 M	14 K	30.9 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Compugen Ltd. CGEN	475 K	$ 2.02	-0.98 %	$ 189 M	Israel
Happiness Biotech Group Limited HAPP	380 K	-	1.35 %	$ 17.8 M	China
Coherus BioSciences CHRS	1.3 M	$ 1.42	-	$ 166 M	USA
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	2.1 M	-	-	$ 2.18 B	USA
Alpine Immune Sciences ALPN	576 K	-	-	$ 2.17 B	USA
AstraZeneca PLC AZN	5.73 B	-	-	$ 96.9 B	Britain
Athira Pharma ATHA	972 K	-	-	$ 269 M	USA
Galera Therapeutics GRTX	20 K	-	-32.59 %	$ 7.61 M	USA
CRISPR Therapeutics AG CRSP	19.5 M	$ 51.48	-0.23 %	$ 4.63 B	Schweiz
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	3.38 M	$ 29.6	3.64 %	$ 1.97 B	USA
Generation Bio Co. GBIO	4.93 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	5 K	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	1.74 M	-	-	$ 384 M	Britain
Gracell Biotechnologies GRCL	58.8 M	-	-	$ 3.37 B	China
Anika Therapeutics ANIK	5.37 M	$ 14.57	-0.21 %	$ 209 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 2.91	-5.52 %	$ 4.79 M	Israel
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	7.72 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 22.79	5.8 %	$ 2.9 B	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA